Migdal Insurance & Financial Holdings’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
FAM
ACH
BG
NAMA
Migdal Insurance & Financial Holdings's CDNA Position: Q1 2022 in Review
Migdal Insurance & Financial Holdings sold out of CareDx (CDNA) in Q1 2022, closing a stake of 85 shares — an estimated $4K sold.
Migdal Insurance & Financial Holdings first reported a position in CDNA in Q4 2020 and held it in 5 quarters. The position peaked at $753K in Q1 2021. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.
- Migdal Insurance & Financial Holdings reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
- Migdal Insurance & Financial Holdings sold 85 CareDx shares in Q1 2022, an estimated $4K.
- Migdal Insurance & Financial Holdings first reported a position in CareDx in Q4 2020 and held it in 5 quarters.
- Migdal Insurance & Financial Holdings's CareDx position peaked at $753K in Q1 2021.
- 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.
Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2022, filed 2 May 2022.